China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

Shares of NYSE:CPHI opened at $0.14 on Monday. The business has a fifty day moving average price of $0.23 and a 200-day moving average price of $0.22. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a 1-year low of $0.12 and a 1-year high of $0.41.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.